AbolerIS Pharma

Developer of innovative immuno-modulators intended for the treatment of transplant rejection, graft-versus-host-disease, and auto-immune diseases. The company's novel and therapeutic approach induces ...

Healthcare

Gosselies, Belgium

Founded 2019

14 employees

Website

Valuation

$30M

Market implied

Share Price

N/A

Total Raised

$49.9M

Last Round

N/A

Investors

+10 other investors

View all 10 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock AbolerIS Pharma's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required